glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven major insurance changes are coming
Pay in 4 interest-free payments of $5.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven major insurance changes are coming](https://img.datawrapper.de/ZJY39/full.png)
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven major insurance changes are coming](https://media-cldnry.s-nbcnews.com/image/upload/t_social_share_1024x768_scale,f_auto,q_auto:best/mpx/2704722219/2025_11/1762302482857_nn_ath_wh_drug_manufacturer_deal_251104_1920x1080-rgjn8i.jpg)
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven major insurance changes are coming](https://i.ytimg.com/vi/t6CAAyoH37o/oardefault.jpg?sqp=-oaymwEYCJUDENAFSFqQAgHyq4qpAwcIARUAAIhC&rs=AOn4CLCe5SaAEu9N2LmMKr3nlunYgvGaVw&usqp=CCk)























